SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: Judy who wrote (5844)10/7/1998 5:04:00 PM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
Judy, next drug to be rolled out is Celebra (MTC's Searle Division's COX-2 drug of which PFE has marketing agreement); drug expected to be approved by the FDA in Jan/Feb. 99. Sold covered calls on PFE.

<OT> What do you see in INTC's chart? I'm still on the sidelines after selling at $86.

Regards.

Anthony